tanker27 wrote:Possibly, but it sounds like Theranos and Holmes are splitting the two. They really don't need a lab, they have a product.....a machine and corresponding software. So now they will focus on the machine and possibly sell/license it to other other labs, hospitals, doctors. Theranos was pretty clear about this when posting that announcement on their website.
Before they can do that, they need to fix their tech and prove to the world that it actually works. Given that Holmes was keeping her own employees in the dark -- if not outright lying to them -- about the company's situation, and the fact that raising any additional capital is going to be all but impossible now, I'd be surprised if they survive long enough to do that.
What do they have right now? A machine that has been certified accurate for only one of the hundreds of tests they claimed it was able to perform, a blood sample container for which FDA approval was withdrawn, and (maybe) a procedure for getting accurate results from standard blood testing machines using smaller-than-normal blood samples. Heck, their lead scientist committed suicide a few years ago after telling his wife "nothing works". Add it all up, and it does not look good.
IMO best case plausible outcome for Theranos/Holmes at this point is that another lab (or possibly a patent troll) buys the IP portfolio at a fire sale price, and the SEC's investigation does not result in criminal charges.